Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06255288Not ApplicableCompleted

Time to Heal (Wound, Healing, Dialogue, Nutrition)

Role: collaborator

NCT06647342Phase 4Recruiting

The Effect of Reduced Bleomycin in Electrochemotherapy Treatment

Role: collaborator

NCT03156478Not ApplicableRecruiting

STOP DIABETES - Knowledge-based Solutions

Role: collaborator

NCT02465086Not ApplicableUnknown

Reasoning Skills in Theory of Mind and Linguistic Tests in the Autistic Population

Role: lead

All 4 trials loaded